Write in a clean editor, then format for Clinical Surgical Oncology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Clinical Surgical Oncology is a peer-reviewed journal published by Elsevier, covering Colorectal Cancer Surgical Treatments, Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Clinical Surgical Oncology 12 (2023) 45–58.
Formats any DOI in Clinical Surgical Oncology style. No sign-up. |
| Publishes research in | Colorectal Cancer Surgical Treatments Pancreatic and Hepatic Oncology Research Hepatocellular Carcinoma Treatment and Prognosis Gastric Cancer Management and Outcomes Sarcoma Diagnosis and Treatment |
| ISSN | 2773-160X |
| Citation impact (2-yr) | 0.61 |
| h-index | 5 |
| Total citations | 127 |
| Open access | Yes |
| Top institutions publishing here | Fudan University |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Colorectal cancer (CRC) is a global health concern, ranking among the leading causes of cancer-related mortality. This review critically evaluates the role of liquid biopsy in detecting minimal residual disease (MRD) in CRC. The increasing incidence, particularly in China, highlights the urgency of innovative approaches for early prediction of recurrence and metastasis. The importance of…
The liver is the main target organ for hematogenous metastases of colorectal cancer, and colorectal liver metastasis is one of the most difficult and challenging situations in the treatment of colorectal cancer. In order to improve the diagnosis and comprehensive treatment in China, the Guidelines have been edited and revised for several times since 2008,…
Secondary malignancies are a late complication of radiation treatment for primary cancer through DNA damage. Specifically after breast cancer radiation, a number of tissues are vulnerable to radiation damage and have increased risk for developing secondary malignancies including lung cancer, esophageal cancer, and contralateral breast cancer. Radiation dose must be minimized to healthy tissues, and…
Liver cancer is currently the third leading cause of cancer-related mortality worldwide. Due to late diagnosis and difficulty in monitoring, there is a pressing need for early detection and recurrence monitoring in patients with liver cancer. Recent advancements in liquid biopsy technology, like circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and exosomes, have made…
Neoadjuvant therapy has been the standard care for borderline resectable or locally advanced pancreatic ductal carcinoma (BR/LA PDAC). The textbook outcome (TO) for curative resection after neoadjuvant therapy (NAT) remains understudied. Patients underwent curative resection for PDAC between 2019 and 2020 were confirmed from the multidisciplinary team (MDT) database prospectively maintained by the Department of…
